Variables |
| Cox Proportional Hazard Method |
| Competing Risk Regression Method | ||||||
Coef. | Std.error | HR | P-value | 95% CI | Coef. | Std.error | SHR | P-value | 95% CI | |
Baseline weight (kg) | 0.008 | 0.754 | 1.008 | 0.026* | 1.001 - 2.014 | 0.015 | 0.328 | 1.015 | <0.001* | 1.009 - 3.021 |
Age group (years) |
|
| ||||||||
18 to 30 (Ref) |
|
| ||||||||
31 to 40 | −0.021 | 0.912 | 0.979 | 0.868 | 0.760 - 1.260 | 0.599 | 0.522 | 1.821 | 0.111 | 0.643 - 1.046 |
41 to 50 | −0.303 | 0.763 | 0.739 | 0.057* | 1.541 - 3.009 | -0.219 | 0.337 | 0.803 | 0.035* | 1.606 - 2.063 |
>50 | −0.101 | 0.744 | 0.904 | 0.622 | 0.603 - 1.353 | 0.582 | 0.461 | 1.790 | 0.244 | 0.531 - 2.175 |
Gender |
|
| ||||||||
Male (Ref) |
|
| ||||||||
Female | 0.052 | 0.865 | 1.053 | 0.638 | 0.849 - 1.307 | -0.175 | 0.246 | 0.840 | 0.098 | 0.683 - 1.033 |
Previous MDR-TB |
|
| ||||||||
No (Ref) |
|
| ||||||||
Yes | 0.751 | 0.559 | 2.118 | 0.319 | 0.575 - 7.802 | 0.667 | 0.295 | 1.949 | 0.223 | 0.326 - 2.758 |
Comorbidities conditions |
|
| ||||||||
No (Ref) |
|
| ||||||||
Yes | −0.229 | 0.831 | 0.795 | 0.015* | 1.225 - 6.378 | −0.144 | 0.362 | 0.866 | 0.004* | 1.400 - 5.865 |
HIV status |
|
|
|
|
|
|
| |||
Positive (Ref) |
|
|
|
|
|
|
|
|
|
|
Negative | 0.096 | 0.750 | 1.100 | 0.045* | 1.859 - 2.410 | 0.068 | 0.278 | 1.070 | 0.041* | 1.851 - 2.346 |
Study sites |
|
|
|
|
|
|
|
|
|
|
Centralised hospital (Ref) |
|
|
|
|
|
|
|
|
|
|
Decentralised sites | −1.290 | 0.924 | 0.275 | 0.024* | 1.090 - 4.842 | −1.667 | 0.499 | 0.189 | 0.002* | 1.067 - 4.536 |